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HIGHLIGHTS 
 UHPLC-DPPH method revealed six antioxidant compounds in Celtis occidentalis twigs 
 The constituents were isolated by flash chromatography and semi preparative HPLC 
 The compounds were first identified in C. occidentalis by Orbitrap® MS and NMR  
 The BBB penetration capability of the compounds was tested by the PAMPA method 
 No constituents in the extract were able to cross the BBB via passive diffusion 
 
Abstract 
Celtis occidentalis L. (common Hackberry, Cannabaceae) has been applied in the traditional 
medicine for a long time as a remedy for sore throat, aid during menstruation and for treating 
jaundice. Nevertheless, the phytochemical exploration of the plant is still incomplete, literature 
data is limited to flavonoid derivatives isolated from the leaves. 
The present study reports screening approaches for bioactive compounds in C. occidentalis by 
fast and simple UHPLC-coupled assays. The UHPLC-DPPH method revealed six constituents 
in the methanolic extract of the twigs that had not been reported in C. occidentalis before. The 
antioxidant compounds were isolated by the means of flash chromatography and semi-
preparative HPLC and identified by Orbitrap® MS and NMR spectroscopy as N-trans-p-
coumaroyloctopamine (1), N-trans-feruloyloctopamine (2), N-trans-caffeoyltyramine (3), 2-
trans-3-(4-hydroxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl] prop-2-enamide (4), N-trans-
p-coumaroyltryramine (5) and N-trans-feruloyltyramine (6). 
Despite the high antioxidant activity measured in the present study and literature data 
suggesting potential positive effects of the compounds in the central nervous system, the 
PAMPA-BBB assay performed with the Celtis extract revealed that none of the aforementioned 
compounds are able to penetrate across the blood-brain barrier via transcellular passive 
diffusion.  
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1. Introduction 
Celtis occidentalis L. (common Hackberry, Cannabaceae) is a deciduous tree commonly found 
and native to North America [1], but it can grow in many other regions like Africa, Europe or 
Australia. It has been reported that native Americans used the bark of the tree as a remedy for 
sore throat and aid during menstruation while the wood extract was used in treating jaundice 
[1]. Despite the long-standing traditional use, the phytochemical exploration of the plant is still 
incomplete, literature data is limited to flavonoid derivatives identified in the leaves [1]. 
Despite the sparse data on the phytochemistry of C. occidentalis, other species of the Celtis 
genus have been proved to contain several biologically active constituents, such as flavonoids, 
phenolic acids, anthocyanins, triterpenes, lignans and amide derivatives with antioxidant, anti-
inflammatory, acetylcholinesterase inhibitory, antimicrobial and antitumor activities [1-6]. 
Therefore, the aim of the present study was searching for bioactive compounds in C. 
occidentalis by fast and simple UHPLC (Ultra High Performance Liquid Chromatography)-
coupled assays. Coupling the DPPH (2,2-diphenyl-1-picrylhydrazyl) in vitro free radical 
scavenging assay to UHPLC separation allows the rapid identification of antioxidant 
constituents in the Celtis extract [7,8], while the transcellular passive diffusion of the 
compounds across biological barriers can be studied by the PAMPA (Parallel Artificial 
Membrane Permeability Assay) method [9]. 
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2. Materials and methods 
2.1. Plant material  
The twigs of Celtis occidentalis L. were collected in Budapest, Hungary 
[47.486899,19.067525] in October, 2019. 28-28 g samples were collected from three trees after 
flowering stage. Plant samples were authenticated in the Department of Pharmacognosy, 
Semmelweis University, Budapest, where voucher specimen is deposited. 
2.2. Solvents and chemicals 
HPLC grade acetic and formic acid, the DPPH free radical p-coumaric acid, ferulic acid, caffeic 
acid, caffeine, rutin and trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) 
standards, dimethyl sulfoxide-d6 (99.8 atom % D with 0.03 vol.% TMS) and methanol-d4 (99.8 
atom % D), cholesterol and the porcine polar brain lipid extract were purchased from Merck 
(Darmstadt, Germany). n-Hexane and methanol of reagent grade, HPLC-MS grade acetonitrile, 
methanol, n-dodecane and dimethyl sulfoxide were obtained from Reanal-Ker (Budapest, 
Hungary). HPLC grade water was prepared with a Millipore Direct Q5 water purification 
system (Bedford, MA, USA). All aqueous eluents for HPLC were filtered through MF-
Millipore membrane filters (0.45 μm, mixed cellulose esters) (Billerica, MA, USA) and 
degassed in an ultrasonic bath before use. 
2.3. Extraction and sample preparation 
Dried and milled plant sample (84 g) was pre-extracted with 840 ml of n-hexane in order to 
eliminate the apolar constituents not of our interest (e.g. chlorophyll), and consecutively with 
840 ml of methanol in an ultrasonic bath at room temperature for 8-8 hours. The n-hexane 
fraction was discarded, while the methanolic extract was evaporated to dryness under reduced 
pressure in a rotary evaporator at 50 ºC. The dried extract (3.45 g) was dissolved in HPLC grade 
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70% aqueous methanol and diluted to obtain sample solution concentrations of 30 mg/ml and 
3.0 mg/ml. The solutions were filtered through Phenex-RC 15 mm, 0.2 μm syringe filters (Gen-
Lab Ltd, Budapest, Hungary). 
2.4. UHPLC-DAD analyses  
The Celtis samples were analyzed by a Waters Acquity Ultra High Performance Liquid 
Chromatogrpahy (UHPLC) system equipped with a diode array detector (DAD) (Waters 
Corporation, Milford, MA, USA) using an Acquity BEH C18 column (2.1×100 mm; 1,7 µm, 
25 °C) with 0.1% formic acid in water as eluent A and acetonitrile as eluent B (from 95:5 to 
70:30 v/v in 10 min) with a flow rate of 0.3 ml/min. The injection volume was 2 μl. UV spectra 
and chromatograms were recorded at 200-400 nm and the max plots were used for data 
evaluation. 
2.5. The DPPH antioxidant activity assay  
Antioxidant activity of the Celtis extract, the isolated compounds and the standards was 
determined using DPPH free radical. Stock solution was prepared by dissolving 10 mg of DPPH 
in 25.0 ml HPLC grade methanol (1.02 mM) and diluted with HPLC grade methanol 10-fold 
just before measuring. In its radical form, DPPH has absorption maxima at 515 nm.  During the 
assay, 50 μl of the samples of five different concentrations, in three parallels were added to 2.5 
ml of the free radical solution and the decrease of the absorbance was measured at 515 nm after 
30 minutes of incubation at room temperature, protected from light by a Hitachi U-2000 
spectrophotometer (Hitachi Ltd., Tokyo, Japan). The percentage of free radical scavenging 
activity was calculated as: Inhibition % = (A0-A/A0) ∙100%, where A=absorbance of the free 
radical solution after reacting with the sample and A0=absorbance of the solution containing 
only the free radical. The percentages of inhibition were plotted vs. the concentrations. The 
concentrations belonging to the half maximal inhibition (IC50 value as μg/ml and μM), were 
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determined by linear regression. The results are expressed as mean values and standard 
deviation (SD). 
2.6. The UHPLC-DPPH assay 
100 µl of the diluted Celtis extract (3.0 mg/ml) dissolved in methanol and 100 µl of the DPPH 
solution (1.2 mg/ml in methanol) were mixed and incubated for 30 minutes at room 
temperature, protected from light. Then the reaction mixture was directly analyzed by UHPLC-
DAD. The control sample was prepared by the addition of 100 µl methanol to 100 µl of the 
extract. 
2.7. The fractionation of the Celtis extract by flash chromatography 
The Celtis extract was fractionated by flash chromatography (CombiFlash Nextgen 100, 
Teledyne Isco, USA) on two RediSep Rf Gold® 15.5g Reversed-phase C18 columns (Teledyne 
Isco, USA) eluting with 0.1% formic in water as eluent A and methanol as eluent B (from 100:0 
to 70:30 v/v in 2 min, to 30:70 v/v in 10 min, to 0:100 v/v in 2 min and 0:100 v/v for 10 min, 
with a flow rate of 10 ml/min). Fourteen fractions (A-N) were obtained on the basis of UV 
chromatograms (290 nm). Fractions C, D and E were further purified by semi preparative 
HPLC.  
2.8. Purification and isolation by semi preparative HPLC  
Fractions C and E were purified by a Hanbon Newstyle NP7000 semi preparative HPLC 
(Hanbon Sci. & Tech. CO. Jiangsu, China) using a Gemini C18 column (150 x 21.2 mm, 5µm, 
25 ºC, Phenomenex Inc.; Torrance, CA, USA), in the case of fraction C, using 0.1% formic acid 
in water as eluent A and methanol as eluent B (from 70:30 to 55:45 v/v in 30 min), while in the 
case of fraction E, 0.1% formic acid in water as eluent A and acetonitrile as eluent B (from 
80:20 to 60:40 v/v in 30 min) with a flow rate of 10 ml/min. Fraction D was separated by a 
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Waters 2690 HPLC system with a Waters 996 diode array detector (Waters Corporation, 
Milford, MA, USA) equipped with a Luna C18 100 A reversed phase column (150 × 10.0 mm, 
5 µm ; Phenomenex Inc; Torrance, CA, USA) using 0.1% formic acid in water as eluent A and 
methanol as eluent B with a flow rate of 3.0 ml/min. Fraction C yielded compounds 1 (4.5 mg) 
and 2 (2.5 mg), compound 3 (1.7 mg) was obtained from fraction D, while compounds 4 (1.1 
mg), 5 (1.0 mg) and 6 (1.2 mg) were isolated from fraction E. 
2.9. Structure elucidation by UHPLC-Orbitrap® Mass Spectrometry 
For obtaining high resolution mass spectrometric data of the isolated compounds (1-6), a 
Dionex Ultimate 3000 UHPLC system (3000RS diode array detector, TCC‐3000RS column 
thermostat, HPG‐3400RS pump, SRD‐3400 solvent rack degasser, WPS‐3000TRS 
autosampler) was used hyphenated with a Orbitrap® Q Exactive Focus Mass Spectrometer 
equipped with electrospray ionization (Thermo Fischer Scientific, Waltham, MA, USA). The 
same chromatographic method was applied as described above. The electrospray ionization 
source was operated in positive ionization mode, and operation parameters were optimized 
automatically using the built‐in software. The working parameters were as follows: spray 
voltage, 2500 V; capillary temperature 320°C; sheath gas (N2), 47.5°C; auxiliary gas (N2), 
11.25 arbitrary units; spare gas (N2), and 2.25 arbitrary units. The resolution of the full scan 
was of 70000, and the scanning range was between 120 and 500 m/z units. Parent ions were 
fragmented with normalized collision energy of 10%, 30%, and 45%. 
2.10. Structure elucidation by NMR spectroscopy 
NMR spectra were recorded in deuterated methanol (Methanol-d4) or in deuterated 
dimethylsulfoxide (DMSO-d6) on a BRUKER AVANCE III HD 600 (600/150 MHz) 
instrument equipped with Prodigy cryo-probehead at 295 K, or on a Varian DDR 600 (600/150 
MHz) equipped with a 5-mm inverse-detection gradient (IDPFG) probehead. at 298 K. The 
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pulse programs were taken from the Bruker or the Varian software library (TopSpin 3.5 or 
VnmrJ 3.2). Chemical shifts (δ) and coupling constants (J) are given in ppm and in Hz, 
respectively. 13C and 1H chemical shifts are given in ppm relative to the NMR solvent or relative 
to tetramethylsilane (TMS) where internal standard was used. The complete 1H and 13C 
assignments were achieved with widely accepted strategies based on 1H NMR, 13C NMR, 
DeptQ, 1H-1H COSY, 1H-13C edHSQC and 1H-13C HMBC measurements. 
2.11. Investigation of blood-brain barrier permeability by the PAMPA-BBB method 
The test solutions were prepared with dimethyl sulfoxide (DMSO) at the concentration of 10.0 
mM for the standards and at 200 mg/ml for the Celtis extract. These were diluted with PBS 
(Phosphate Buffer Saline; pH = 7.4) to obtain the donor solutions (270.0 μl buffer+3.0 μl 
DMSO solution) and filtered through Phenex-RC 15 mm, 0.2 μm syringe filters (Gen-Lab Ltd, 
Budapest, Hungary). A parallel artificial membrane permeability assay (PAMPA) system was 
used to determine the effective permeability (Pe) for the compounds of interest. Each well of 
the top plate (96-well polycarbonate based filter donor plates (Multiscreen™-IP, MAIPN4510, 
pore size 0.45 μm; Millipore)) was coated with 5 μl of porcine polar brain lipid extract (PBLE) 
solution (16.0 mg PBLE + 8.0 mg cholesterol dissolved in 600.0 μl n-dodecane), then 150.0 μl 
of the filtrate was placed on the membrane. The bottom plate (96-well PTFE acceptor plates 
(Multiscreen Acceptor Plate, MSSACCEPTOR; Millipore)), was filled with 300.0 μl buffer 
solution (0.01 M PBS buffer, pH= 7.4). The donor and acceptor plates were fit, and then the 
sandwich system was incubated at 37 °C for 4 hours in a Stat-Fax 2200. After the incubation 
the PAMPA plates were separated and the compound concentrations in the donor (CD(t)) 
solution, as well as in the donor solution at zero time point (CD(0)) were determined by UPLC-
DAD. Since in our experiment no peaks were detected in the acceptor phase, concentrations 
(CA(t)) were not determined, thus calculation of the effective permeability according to Avdeef 
[10] was not performed. 
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standard was used as positive, while rutin standard as negative control. 
 
3. Results and Discussion 
 
3.1. The UHPLC-DPPH assay 
Based on the results of the in vitro antioxidant activity test using DPPH free radical, it could be 
concluded that the Celtis extract possessed notable free radical scavenger activity (with IC50 
value of 60.54 μg/ml). In order to gain information about the constituents presumably 
responsible for the activity of the extract, the DPPH assay was coupled to UHPLC separation. 
It has previously been demonstrated that the chromatographic peak areas of constituents 
presenting antioxidant activity significantly decrease after the addition of free radical solution 
to the extract, whereas no change can be observed regarding the peaks of compounds without 
scavenging activity [7,8]. Therefore, the applied UHPLC-coupled assay allows the rapid 
identification of the antioxidant constituents in such complex mixtures as plant extracts. 
Six main compounds were detected in the Celtis extract by UHPLC-DAD (Figure 1). Based on 
the decrement in the peak areas after the addition of the DPPH free radical, compounds 2, 3 and 
6 were supposed to possess high, while compounds 1, 4 and 5 moderate scavenging capacity.  
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 Figure 1. UHPLC-DAD chromatograms of the control sample and the sample after spiking 
with DPPH of Celtis occidentalis twigs methanolic extract. 
 
For further investigation of the antioxidant activity, and in order to gain information about the 
structures of the aforementioned compounds, isolation was carried out by flash 
chromatographic fractionation followed by semi preparative HPLC purification.  
3.2. Structure elucidation by UHPLC-Orbitrap® MS and NMR  
The isolated compounds were identified by Orbitrap® mass spectrometry hyphenated to 
UHPLC separation and by NMR spectroscopy. In the mass spectrometric experiments all the 
six compounds exhibited molecular ions [M+H]+ with even m/z values, indicating the presence 
of odd number of nitrogen atoms in their molecules (Table 1).  
In the mass spectra of compounds 1, 4 and 5 characteristic fragment ions at m/z 147.0437, 
119.0492, 91.0547 (Table 1) were detected suggesting a coumaroyl moiety [11]. The calculated 
molecular formula of compound 5 ([M+H]+ m/z 284.1270, C17H17NO3) together with the 
aforementioned product ions suggested the compound to be N-trans-p-coumaroyltyramine 
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(Figure 2), a compound that had previously been isolated from Celtis africana [6]. This 
presumption was further confirmed by NMR spectroscopy. The 1H NMR spectrum showed 
resonances at δ 7.37 (d, J=8.6 Hz, 2H, H-2, H-6), 7.00 (d, J=8.3 Hz, 2H, H-2’, H-6’), 6.78 (d, 
J=8.6 Hz, 2H, H-3, H-5) and 6.67 (d, J=8.3 Hz, 2H, H-3’, H-5’) ppm which indicated the 
presence of two para-substituted aromatic rings. The resonance at δ 8.02 (br t, J=5.7 Hz, 1H, 
H-10) ppm with no HSQC correlation confirmed the amide structure. The resonances at δ 2.63 
(m, 2H, H-7’) and 3.31 (m, 2H, H-8’) ppm revealed the presence of two methylene units. 
Furthermore, two olefinic 1H resonances appeared at δ 7.30 (d, J=15.7 Hz, 1H, H-7) and 6.39 
(d, J=15.7 Hz, 1H, H-8) ppm, their coupling constant suggested trans configuration of the 
double bond. The presence of two extra olefinic 1H resonances with lower relative intensities 
at δ 6.48 (d, J=13.0 Hz, H-7) and 5.75 (d, J=13.0 Hz, H-8) ppm and smaller coupling constant 
values suggested the presence of the cis isomer as well. The 1H NMR resonances were similar 
to that of previously reported [12]. 
  
Figure 2. Structure of the isolated compounds (1-6) 
In the case of compound 1, besides the aforementioned product ions, a characteristic ion formed 
by the neutral loss of 18.0105 amu ([M+H]+ m/z 300.1221 → [M-H2O+H]+ m/z 282.1116) 
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(Table 1) from the molecular ion was also detected in the mass spectrum, suggesting the 
presence of a primary or secondary hydroxyl group in the molecule. This was also confirmed 
by the calculated molecular formula differing from that of compound 5 in one oxygen atom 
(C17H17NO4). The 
1H NMR spectrum of compound 1 showed analogous resonances with 
compound 5 however instead of the methylene group adjacent to the aromatic ring an 
oxymethine resonance at δ 4.76 (m, 1H, H-7’) ppm appeared indicating the presence of a 
hydroxyl group in the aliphatic chain. Thus, the compound was identified as N-trans-p-
coumaroyloctopamine (Figure 2), although octopamine derivatives have not been reported in 
Celtis species yet. The 1H NMR spectrum was similar to that of previously reported [13]. 
The calculated molecular formula of compound 4 ([M+H]+ m/z 298.1063, C17H15NO4) differed 
from that of compound 1 in two hydrogen atoms, therefore the presence of a carbonyl group 
instead of a hydroxyl group was supposed in C7’ position (Figure 2) The 1H NMR spectrum of 
the compound was similar to that of compound 1. The 1H NMR spectrum confirmed the lack 
of the oxymethine group, while the 13C NMR and the HMBC spectra of compound 4 supported 
the presence of a carbonyl group in the C7’ position at δ 193.5 ppm, therefore the compound 
was identified as 2-trans-3-(4-hydroxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl] prop-2-
enamide, although the proposed structure was found neither in Reaxys nor in Pubchem nor in 
SciFinder databases, which allows us to draw the conclusion that compound 4 can be considered 
a new compound. 
In the mass spectra of compounds 2 and 6 characteristic fragment ions at m/z 177.0542, 
145.0281, 117.0335, 89.0390 (Table 1) were detected suggesting a feruloyl moiety [11]. The 
calculated molecular formula of compound 6 ([M+H]+ m/z 314.1374, C18H19NO4) together with 
the aforementioned product ions corresponded to N-trans-feruloyltyramine (Figure 2), a 
compound previously isolated from Celtis africana [6], which presumption was further 
confirmed by NMR spectroscopy. The 1H NMR spectrum of compound 6 showed similar 1H 
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NMR pattern to compound 5, however compound 6 exhibited resonances at δ 7.11 (d, 4JH,H=1.9 
Hz, 1H, H-2), 6.97 (dd, 3JH,H =8.2 Hz, 
4JH,H =1.9 Hz, 1H, H-6) and 6.79 (d, 
3JH,H =8.2 Hz, 1H, 
H-5) ppm. These three aromatic resonances along with their coupling constants indicated a 
1,2,4-trisubstitued aromatic moiety. The resonance at δ 3.80 (s, 3H, H-11) ppm suggested a 
methoxy group at position 11. The 1H NMR resonances were analogous to literature data [12]. 
In the case of compound 2, besides the aforementioned product ions, a characteristic ion formed 
by the neutral loss of 18.0105 amu ([M+H]+ m/z 330.1325 → [M-H2O+H]+ m/z 312.1219) 
(Table 1) from the molecular ion was also detected, suggesting the presence of a primary or 
secondary hydroxyl group in the molecule, which was also confirmed by the calculated 
molecular formula differing from that of compound 6 in one oxygen atom (C18H19NO5). The 
1H NMR spectrum of compound 2 had analogous resonances with compound 6, however it 
presented an oxymethine signal at δ 4.53 (dd, J=8.0, 4.7 Hz, 1H, H-7’) ppm rather than a 
methylene group. This indicated the presence of a hydroxyl group in the aliphatic moiety. Thus, 
the compound was identified as N-trans-feruloyloctopamine (Figure 2). The 1H NMR spectrum 
was similar to that of published earlier [14]. 
The calculated molecular formula ([M+H]+ m/z 300.1220, C17H17NO4) of compound 3 
indicated it being an isomer of N-trans-p-coumaroyloctopamine (compound 1), but the product 
ions in the mass spectrum at m/z 163.0385, 145.0281, 121.0647, 107.0493 (Table 1) suggested 
compound 3 being a caffeic acid derivative [11], thus it was identified as N-trans-p-
caffeoyltyramine (Figure 2), a compound previously isolated from C. africana [6]. Using the 
1D and 2D NMR data acquired in the case of compound 3 confirmed its structure as the 
desmethyl derivative of compound 6. The NMR spectra was identical to that of a previous report 
[15]. 
All the 1H, 13C, COSY, HSQC and HMBC NMR spectra measured for compounds 1-6 can be 
found in the Supporting information.  
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It has to be noted that although the NMR studies confirmed the presence of both the cis and 
trans isomers of the compounds in the isolated samples, spiking the extract with the mixture of 
the two isomers, presenting peaks with baseline separation (resolution > 2 in all cases) by 
UHPLC, clearly showed that only the trans isomers were originally present in the extract. The 
interconversion between the cis-trans isomers might have occurred rapidly due to unavoidable 
exposure to UV light during the isolation process.  
 
No. 
tR 
(min) 
[M+H]+m/z 
exp. 
Error 
(ppm) 
Molecular 
formula 
Product ions Compound 
1 6.0 300.1221 -3,214 C17H17NO4 
282.1116 
147.0437 
119.0492 
91.0547 
 
N-trans-p-coumaroyloctopamine 
 
2 6.3 330.1325 -3.390 C18H19NO5 
312.1219 
177.0542 
145.0281 
117.0335 
89.0390 
 
N-trans-feruloyloctopamine 
 
4 8.0 298.1063 -3.571 C17H15NO4 
147.0437 
119.0491 
91.0547 
65.03934 
 
2-trans-3-(4-hydroxyphenyl)-N-[2-(4-
hydroxyphenyl)-2-oxoethyl]prop-2-
enamide 
 
5 8.2 284.1270 -3.942 C17H17NO3 
147.0437 
119.0491 
91.0547 
N-trans-p-coumaroyltyramine 
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 6 8.5 314.1374 -4.026 C18H19NO4 
177.0541 
145.0280 
121.0647 
117.0335 
93.0703 
89.0390 
N-trans-feruloyltyramine 
 
Table 1. Orbitrap® MS data of compounds 1-6. 
3.3. Antioxidant activity of the isolated compounds  
The antioxidant activity of the isolated compounds was determined by in vitro tests using DPPH 
free radical.  The IC50 values were compared to Trolox, p-coumaric acid, ferulic acid and caffeic 
acid standards. The results are in good agreement with the conclusions drawn from the UHPLC-
DPPH experiment (Table 2). 
 
Sample 
IC50  
(μg/ml) DPPH 
IC50  
(μM) DPPH 
Trolox 4.9±0.1 19.6±0.4 
p-Coumaric acid 161.3±9.7 983±59.2 
Ferulic acid 6.8±0.3 35.2±1.7 
Caffeic acid 4.6±0.3 25.6±1.7 
Methanolic extract 60.4±0.3 - 
N-trans-p-coumaroyloctopamine (1) 412.7±10.2 1380.3±34.1 
N-trans-feruloyloctopamine (2) 30.9±0.6 94.04±1.8 
N-trans-caffeoyltyramine (3) 9.5±0.4 31.6±1.4 
Jo
urn
al 
Pre
-p
of
 Table 2. DPPH scavenging activity of the Celtis extract, isolated compounds and standards 
 
N-trans-caffeoyltyramine (3) was shown to possess the highest radical scavenging activity 
followed by N-trans-feruloyltyramine (6) and N-trans-feruloyloctopamine (2), all exceeding 
the activity of the whole extract. The coumaroyl derivatives (compounds 1, 4, and 5) exerted 
relatively low activity compared to the whole extract and Trolox standard as well (Table 2). 
These aforementioned results do not come as a surprise, since the scavenging ability of 
hydroxycinnamic acid derivatives against free radicals strongly depends on the number of 
hydroxyl groups on the benzene ring (two in the case of caffeic acid compared to one in p-
coumaric acid) and the ortho-substitution with the electron donor methoxy group (in the case 
of ferulic acid) that increase the stability of the phenoxy radical, resulting in higher scavenger 
activity.  
Our results regarding the DPPH scavenging capacity of N-trans-caffeoyltyramine (3) and N-
trans-feruloyltyramine (6) (Table 2) are in good accordance with literature data as well: Al-
Taweel et al. reported IC50 values of 26.3±0.32 μM and 33.2±0.14 μM, respectively [6]. 
However, the IC50 value of  N-trans-p-coumaroyltyramine (5) showed significant difference 
when compared to the results of the previously mentioned study (62.0±0.15 μM vs. 
1377.7±57.6 μM). Furthermore, in our experiments, the other p-coumaric acid derivatives 
(compounds 1 and 4) possessed relatively high IC50 values as well, similar to that of N-trans-p-
coumaroyltyramine (5) (Table 2). Since literature data regarding the DPPH scavenging activity 
2-trans-3-(4-hydroxyphenyl)-N-[2-(4-
hydroxyphenyl)-2-oxoethyl]prop-2-enamide (4) 
349.7±15.4 1177.4±51.9 
N-trans-p-coumaroyltyramine (5) 389.9±16.3 1377.7±57.6 
N-trans-feruloyltyramine (6) 15.0±0.6 47.9±1.9 
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of p-coumaric acid is, to put it mildly, diverse (Table 3), it was determined together with the 
isolated compounds as well as ferulic acid and caffeic acid standards. As it can be seen in Table 
2, all the isolated derivatives showed significantly lower activity than the corresponding 
phenolic acids, and for p-coumaric acid the IC50 value of 983±59.2 μM was measured. Based 
on these observations, the results regarding the p-coumaric acid derivatives (compounds 1, 4 
and 5) were found to be acceptable despite the significantly different result for N-trans-p-
coumaroyltyramine (5) of Al-Taweel et al. [6]. 
Concentration / Inhibitory % 
Incubation 
time 
Reference 
caffeic acid ferulic acid p-coumaric acid DPPH   
no data no data 762.2 µM / 6.99% 1500 µM 30 min [16] 
39.6 µM / 50.0% 60. 56 µM / 50.0% 7819.8 µM / 50.0% 75 µM 30 min [17] 
166.7 µM / 32.1%  no data  182.9 µM / 5.3% 80 µM 10 min [18] 
no data no data 182.9 µM /55.6% 25 µM 30 min [19] 
20.0 µM / 49.6.0% 20.0 µM / 27.3% 20.0 µM / 7.0% 100 µM 30 min [20] 
 
Table 3. Literature data regarding the DPPH scavenging activity of p-coumaric acid, ferulic 
acid and caffeic acid 
 
It is also worth mentioning, that interestingly, compounds 2, 3 and 6 showed significantly 
higher antioxidant activity than the whole extract, which suggest antagonistic interactions 
between the constituents. 
 
3.4. Investigation of blood-brain barrier permeability by the PAMPA-BBB method 
Besides the antioxidant activity reported here, the isolated compounds have been shown to 
possess other beneficial biological effects as well, for instance N-trans-p-coumaroyl tyramine 
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from C. chinensis reversibly inhibited acetylcholinesterase activity in a dose-dependent manner 
(IC50 34.5 μg/ml) [5]. 
Taken in consideration the aforementioned effect together with the antioxidant activity of the 
Celtis constituents, in order to get information about the ability of the compounds to reach the 
central nervous system, the investigation of their transcellular passive diffusion across the 
blood-brain barrier (BBB) was found to be reasonable. For this purpose, the PAMPA-BBB 
assay was chosen that had previously been validated for natural compounds [9]. Coupling the 
PAMPA-BBB method to UHPLC separation allowed the rapid simultaneous investigation of 
the membrane penetration capability of the constituents present in the Celtis extract. As it can 
be seen in Figure 3, none of the compounds were detected in the acceptor phase of the PAMPA-
BBB model, indicating their inability to cross the BBB via passive diffusion.  
 
 
Figure 3. Result of the PAMPA BBB experiment of Celtis occidentalis twigs methanolic 
extract 
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4. Conclusions  
The UHPLC-coupled DPPH assay followed by isolation and structure elucidation allowed the 
identification of six antioxidant constituents in Celtis occidentalis twigs methanolic extract: N-
trans-p-coumaroyloctopamine (1), N-trans-feruloyloctopamine (2), N-trans-caffeoyltyramine 
(3), 2-trans-3-(4-hydroxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl] prop-2-enamide (4), N-
trans-p-coumaroyltryramine (5) and N-trans-feruloyltyramine (6).  
All the six compounds are reported in Celtis occidentalis for the first time, N-trans-p-
coumaroyloctopamine (1) and N-trans-feruloyloctopamine (2) have not been identified in 
Celtis species yet, while 2-trans-3-(4-hydroxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl] 
prop-2-enamide (4) can be considered a new compound. 
Besides the antioxidant activity reported here, literature data indicates further beneficial 
pharmacological effects of the isolated compounds, for instance N-trans-p-
coumaroyloctopamine (1) and N-trans-feruloyloctopamine (2) from garlic skin have been 
reported to attenuate oxidative stress and liver pathology in rats with non-alcoholic 
steatohepatitis [13], while N-trans-p-coumaroyltyramine (5) from C. chinensis has been shown 
to reversibly inhibit acetylcholinesterase activity in a dose-dependent manner [5]. 
The recent study highlights the importance of C. occidentalis as a new natural source of the 
aforementioned compounds with potential beneficial biological effects, and also reports 
compound 4, a new natural compound with antioxidant activity and pharmacological 
perspectives that can be explored in the future. However, the result of the PAMPA-BBB 
experiments indicates that none of the compounds are able to penetrate across the BBB via 
passive diffusion, thus, a special emphasis should be placed on this issue in future studies 
aiming the investigation of the potential effects of the compounds in the central nervous system. 
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